Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDCaris Life Sciences Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 6 | -$0.07 | $0.04 | -$0.02 |
| Q2 2026 | 6 | -$0.01 | $0.05 | $0.01 |
| Q3 2026 | 6 | $0.05 | $0.05 | $0.05 |
| Q4 2026 | 4 | $0.08 | $0.09 | $0.08 |
| Q1 2027 | 2 | $0.04 | $0.05 | $0.05 |
| Q2 2027 | 2 | $0.09 | $0.09 | $0.09 |
| Q3 2027 | 2 | $0.11 | $0.11 | $0.11 |
| Q4 2027 | 2 | $0.12 | $0.13 | $0.13 |
| Q1 2028 | 3 | $0.11 | $0.11 | $0.11 |
| Q2 2028 | 3 | $0.12 | $0.13 | $0.12 |
| Q3 2028 | 3 | $0.13 | $0.14 | $0.14 |
| Q4 2028 | 3 | $0.14 | $0.15 | $0.14 |
Caris Life Sciences Inc. Earnings Date And Information
Caris Life Sciences Inc. last posted its earnings results on Thursday, May 7th, 2026. The company reported $-0.0018 earnings per share for the quarter, topping analysts' consensus estimates of $-0.02411 by $0.02231. The company had revenue of 216.17 M for the quarter and had revenue of 812.03 M for the year. Caris Life Sciences Inc. has generated $-2 earnings per share over the last year ($-1.9 diluted earnings per share) and currently has a price-to-earnings ratio of 122.15. Caris Life Sciences Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
Caris Life Sciences Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 05/08/2026 | Q1 2026 | N/A | -$0.00 | N/A | $209.42 M | $216.17 M |
| 02/26/2026 | Q4 2025 | -$0.02 | $0.29 | 0.31 | $240.39 M | $292.89 M |
| 11/05/2025 | Q3 2025 | -$0.08 | $0.09 | 0.17 | $174.05 M | $216.83 M |
| 08/12/2025 | Q2 2025 | -$0.21 | -$1.93 | -1.72 | $138.04 M | $181.40 M |
| 03/31/2025 | Q1 2025 | N/A | -$0.40 | N/A | N/A | $120.92 M |
| 06/30/2024 | Q2 2024 | N/A | -$0.35 | N/A | N/A | $100.05 M |
| 03/31/2024 | Q1 2024 | N/A | -$0.53 | N/A | $109.86 M | $80.68 M |
| 11/05/2021 | Q3 2021 | N/A | $2.95 | N/A | N/A | $100.83 M |
| 08/03/2021 | Q2 2021 | N/A | $2.20 | N/A | N/A | $85.70 M |
| 04/30/2021 | Q1 2021 | N/A | $2.07 | N/A | N/A | $80.80 M |
| 03/01/2021 | Q4 2020 | N/A | $0.80 | N/A | N/A | $64.32 M |
| 11/02/2020 | Q3 2020 | N/A | $0.88 | N/A | N/A | $79.05 M |
| 08/07/2020 | Q2 2020 | N/A | -$0.04 | N/A | N/A | $75.73 M |
| 05/05/2020 | Q1 2020 | N/A | -$0.08 | N/A | N/A | $105.02 M |
| 03/05/2020 | Q4 2019 | N/A | $0.45 | N/A | N/A | $100.17 M |
| 11/01/2019 | Q3 2019 | N/A | -$0.27 | N/A | N/A | $107.57 M |
| 08/07/2019 | Q2 2019 | N/A | $0.53 | N/A | N/A | $105.58 M |
| 05/03/2019 | Q1 2019 | N/A | $1.00 | N/A | N/A | $111.11 M |
| 03/05/2019 | Q4 2018 | N/A | $1.02 | N/A | N/A | $115.57 M |
| 11/02/2018 | Q3 2018 | N/A | $1.13 | N/A | N/A | $115.45 M |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Caris Life Sciences Inc. Earnings: FAQ's
In the previous quarter, Caris Life Sciences Inc. (:CAI) reported $-0.0018 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.02411 by $0.02231.
The conference call for Caris Life Sciences Inc.'s latest earnings report can be listened to online.
The conference call transcript for Caris Life Sciences Inc.'s latest earnings report can be read online.
Caris Life Sciences Inc. (:CAI) has a recorded annual revenue of $812.03 M.
Caris Life Sciences Inc. (:CAI) has a recorded net income of $-537,957,000.Caris Life Sciences Inc. has generated $-1.9 earnings per share over the last four quarters.
Caris Life Sciences Inc. (:CAI) has a price-to-earnings ratio of 122.15 and price/earnings-to-growth ratio is -0.64.